These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7653961)

  • 1. Mutations of the tumour suppressor gene p53 in colorectal and hepatocellular carcinomas.
    Shi CY; Phang TW; Wee A; Ngoi SS; Lin Y; Li B; Ong CN; Lee HP
    Ann Acad Med Singap; 1995 Mar; 24(2):204-10. PubMed ID: 7653961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of p53 gene mutations in colorectal carcinomas from an Asian population.
    Shi CY; Phang TW; Ngoi SS; Wee A; Li B; Lin Y; Lee HP; Ong CN
    Anticancer Res; 1994; 14(6B):2811-6. PubMed ID: 7872723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India.
    Katiyar S; Dash BC; Thakur V; Guptan RC; Sarin SK; Das BC
    Cancer; 2000 Apr; 88(7):1565-73. PubMed ID: 10738214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Codon 249 mutation of the p53 gene is a rare event in hepatocellular carcinomas from ethnic Chinese in Singapore.
    Shi CY; Phang TW; Lin Y; Wee A; Li B; Lee HP; Ong CN
    Br J Cancer; 1995 Jul; 72(1):146-9. PubMed ID: 7599044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the p53 tumor-suppressor gene in hepatocellular carcinomas from Britain.
    Challen C; Lunec J; Warren W; Collier J; Bassendine MF
    Hepatology; 1992 Dec; 16(6):1362-6. PubMed ID: 1332921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer.
    Notarnicola M; Cavallini A; Cardone R; Pezzolla F; Demma I; Di Leo A
    Dig Liver Dis; 2000 Mar; 32(2):131-6. PubMed ID: 10975788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A detailed study of p53 mutations in colorectal cancer in Singapore.
    Smith DR; Chan CS; Goh HS
    Ann Acad Med Singap; 1994 Nov; 23(6):803-9. PubMed ID: 7741489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 abnormalities in hepatocellular carcinoma from United States patients: analysis of all 11 exons.
    Kazachkov Y; Khaoustov V; Yoffe B; Solomon H; Klintmalm GB; Tabor E
    Carcinogenesis; 1996 Oct; 17(10):2207-12. PubMed ID: 8895490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A universal method for the mutational analysis of K-ras and p53 gene in non-small-cell lung cancer using formalin-fixed paraffin-embedded tissue.
    Sarkar FH; Valdivieso M; Borders J; Yao KL; Raval MM; Madan SK; Sreepathi P; Shimoyama R; Steiger Z; Visscher DW
    Diagn Mol Pathol; 1995 Dec; 4(4):266-73. PubMed ID: 8634783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene mutation spectrum in hepatocellular carcinomas in Hong Kong Chinese.
    Ng IO; Chung LP; Tsang SW; Lam CL; Lai EC; Fan ST; Ng M
    Oncogene; 1994 Mar; 9(3):985-90. PubMed ID: 8108145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrations of p53 gene in human hepatocellular carcinoma from China.
    Li D; Cao Y; He L; Wang NJ; Gu JR
    Carcinogenesis; 1993 Feb; 14(2):169-73. PubMed ID: 8382111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.
    Honda K; Sbisà E; Tullo A; Papeo PA; Saccone C; Poole S; Pignatelli M; Mitry RR; Ding S; Isla A; Davies A; Habib NA
    Br J Cancer; 1998 Mar; 77(5):776-82. PubMed ID: 9514057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression and point mutations of p53 tumor suppressor gene in hepatocellular carcinomas in Hong Kong Chinese people.
    Ng IO; Srivastava G; Chung LP; Tsang SW; Ng MM
    Cancer; 1994 Jul; 74(1):30-7. PubMed ID: 8004579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
    Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
    Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1.
    Devereux TR; Stern MC; Flake GP; Yu MC; Zhang ZQ; London SJ; Taylor JA
    Mol Carcinog; 2001 Jun; 31(2):68-73. PubMed ID: 11429783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations detected in colorectal carcinoma patients in Hong Kong.
    Leung CS; Cheung MH; Wong CM; Lau KW; Tang CM; Lung ML
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):925-30. PubMed ID: 9367066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.
    Liu H; Wang Y; Zhou Q; Gui SY; Li X
    World J Gastroenterol; 2002 Jun; 8(3):480-2. PubMed ID: 12046074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.
    Lin Y; Shi CY; Li B; Soo BH; Mohammed-Ali S; Wee A; Oon CJ; Mack PO; Chan SH
    Ann Acad Med Singap; 1996 Jan; 25(1):22-30. PubMed ID: 8779541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.